Company attributes
Venture Capital Firm attributes
Other attributes
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million under management and looks to invest in digital health, diagnostics, medical devices, therapeutics and healthcare services. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Glide Healthcare Partners' investments include AM Pharma, SANIFIT, CVRx, Vesper Medical, Calypso Biotech, Lumeon, Vapotherm, Lava Therapeutics, Axonics Modulation Technologies and Inari Medical.
Their exited investments include Evotec, Axonics Modulation Technologies, Innate Pharma, Vapotherm, Ascendis Pharma, Galapagos, Ablynx, Definiens and Breath Therapeutics.
